Literature DB >> 21851931

Studies on the synthesis of Lewis-y oligosaccharides.

Pintu K Mandal1, W Bruce Turnbull.   

Abstract

Lewis-y histo-blood group oligosaccharides are tumour-associated antigens prevalent in several different types of cancer, and they may also be secondary ligands for bacterial toxins from Escherichia coli and Vibrio cholerae. The key step in the synthesis of these sterically congested oligosaccharides involves difucosylation of partially protected lactosamine derivatives. Existing methods require either prolonged reaction times or elaborate glycosyl donors to ensure high stereoselectivity. Herein we report an optimised procedure for using a simple thioglycoside donor that leads to the desired products in high yield and excellent stereoselectivity. It is found that initial glycosylation of the 3'-hydroxy group of lactosamine derivatives in dichloromethane solution can inhibit subsequent glycosylation at the 2-position; however, reaction in toluene solution leads to Lewis-y oligosaccharides in high yield.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21851931     DOI: 10.1016/j.carres.2011.07.002

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  3 in total

1.  An expeditious synthesis of blood-group antigens, ABO histo-blood group type II antigens and xenoantigen oligosaccharides with amino type spacer-arms.

Authors:  Geeta Karki; Vijay Nath Mishra; Pintu Kumar Mandal
Journal:  Glycoconj J       Date:  2015-11-14       Impact factor: 2.916

2.  Towards a structural basis for the relationship between blood group and the severity of El Tor cholera.

Authors:  Pintu K Mandal; Thomas R Branson; Edward D Hayes; James F Ross; Jose A Gavín; Antonio H Daranas; W Bruce Turnbull
Journal:  Angew Chem Int Ed Engl       Date:  2012-04-05       Impact factor: 15.336

3.  Co‑expression of Lewis y antigen and CD147 in epithelial ovarian cancer is correlated with malignant progression and poor prognosis.

Authors:  Juanjuan Liu; Qi Liu; Yanyan Wang; Miao Liu; Yue Qi; Jian Gao; Bei Lin
Journal:  Int J Mol Med       Date:  2019-02-20       Impact factor: 4.101

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.